Alnylam Pharmaceuticals
ALNY
#663
Rank
A$47.00 B
Marketcap
$364.41
Share price
-8.67%
Change (1 day)
38.72%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: A$47.00 Billion

As of November 2024 Alnylam Pharmaceuticals has a market cap of A$47.00 Billion. This makes Alnylam Pharmaceuticals the world's 663th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024A$47.00 B33.31%
2023A$35.25 B-17.94%
2022A$42.96 B53.58%
2021A$27.97 B42.46%
2020A$19.63 B6.41%
2019A$18.45 B76.24%
2018A$10.47 B-35.12%
2017A$16.13 B262.08%
2016A$4.45 B-59.46%
2015A$10.99 B20.17%
2014A$9.15 B99.14%
2013A$4.59 B398.47%
2012A$0.92 B171.43%
2011A$0.33 B-17.37%
2010A$0.41 B-49.91%
2009A$0.82 B-43.47%
2008A$1.45 B7.04%
2007A$1.35 B34.83%
2006A$1.00 B185.67%
2005A$0.35 B89.15%
2004A$0.18 B

End of Day market cap according to different sources

On Nov 15th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

A$47.00 Billion
by Yahoo Finance info icon info icon
A$47.00 Billion
by CompaniesMarketCap info icon info icon
A$47.00 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$3.57 B-92.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$128.65 B 173.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.44 B-67.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.73 B-96.32%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$322.69 B 586.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$194.21 B 313.21%๐Ÿ‡ซ๐Ÿ‡ท France
A$28.84 B-38.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel